Changes in nocturnal and peak acid outputs after duodenal ulcer healing with sucralfate or ranitidine.
Open Access
- 1 February 1992
- Vol. 33 (2) , 175-178
- https://doi.org/10.1136/gut.33.2.175
Abstract
Changes in basal and stimulated acid secretion after duodenal ulcer healing have been previously shown to be influenced by the nature of the treatment. This study aimed to determine possible changes in nocturnal acid secretion on duodenal ulcer healing in patients treated with sucralfate or ranitidine. Nocturnal acid output and peak acid output in response to pentagastrin stimulation were studied in 20 patients before and after duodenal ulcer healing with sucralfate (n = 9) or ranitidine (n = 11). Details regarding cigarette smoking were obtained from each subject. Median 10 hour nocturnal acid output fell significantly (p less than 0.05) from 82.4 (29.1-188.3) mmol (median range) to 45.2 (14.7-144.4) mmol after healing with sucralfate, and rose significantly (p less than 0.05) from 54.7 (16.8-74.3) mmol to 86.2 (11.7-118.1) mmol after ulcer healing with ranitidine. Peak acid output fell from 39.6 (22.0-52.8) mmol/hour to 27.8 (13.8-38.2) mmol/hour (p less than 0.01) after healing with sucralfate and was unchanged after healing with ranitidine. There was no correlation between smoking and nocturnal acid output. These results provide further evidence that acid secretion decreases with sucralfate healing and remains the same or may even increase after ranitidine healing.Keywords
This publication has 14 references indexed in Scilit:
- Duodenal ulcer healing and acid secretory responses to modified sham feeding and pentagastrin stimulationAlimentary Pharmacology & Therapeutics, 2007
- Lack of gastric acid rebound after stopping a successful short-term course of nizatidine in duodenal ulcer patients.1991
- Is there an optimal degree of acid suppression for healing of duodenal ulcers?Gastroenterology, 1990
- Acid-secretory response and parietal cell sensitivity in patients with duodenal ulcer before and after treatment with sucralfate or ranitidineThe American Journal of Medicine, 1989
- Rebound nocturnal hypersecretion after four weeks treatment with an H2 receptor antagonist.Gut, 1989
- Increased parietal cell responsiveness to tetragastrin in patients with recurrent duodenal ulcerDigestive Diseases and Sciences, 1988
- Alteration of H2 receptor sensitivity in duodenal ulcer patients after maintenance treatment with an H2 receptor antagonist.Gut, 1988
- Acid, pepsin, and mucus secretion in patients with gastric and duodenal ulcer before and after colloidal bismuth subcitrate (De-Nol).Gut, 1986
- Augmented Postprandial Gastric Acid Secretion Due to Exposure to Ranitidine in Healthy SubjectsScandinavian Journal of Gastroenterology, 1986
- Parietal and Chief Cell Sensitivity to Pentagastrin Stimulation before and after Cimetidine Treatment for Duodenal UlcerScandinavian Journal of Gastroenterology, 1979